|
|
cellular amide metabolic process
|
GO:0043603 |
58 |
0.979
|
|
|
|
oxidation reduction process
|
GO:0055114 |
342 |
0.970
|
|
|
|
monocarboxylic acid metabolic process
|
GO:0032787 |
191 |
0.954
|
|
|
|
small molecule catabolic process
|
GO:0044282 |
71 |
0.885
|
|
|
|
monocarboxylic acid catabolic process
|
GO:0072329 |
27 |
0.768
|
|
|
|
organic acid catabolic process
|
GO:0016054 |
51 |
0.738
|
|
|
|
fatty acid oxidation
|
GO:0019395 |
28 |
0.729
|
|
|
|
carboxylic acid catabolic process
|
GO:0046395 |
51 |
0.720
|
|
|
|
cellular modified amino acid metabolic process
|
GO:0006575 |
63 |
0.711
|
|
|
|
peptide metabolic process
|
GO:0006518 |
46 |
0.702
|
|
|
|
cellular lipid metabolic process
|
GO:0044255 |
323 |
0.700
|
|
|
|
short chain fatty acid catabolic process
|
GO:0019626 |
2 |
0.677
|
|
|
|
glutathione metabolic process
|
GO:0006749 |
16 |
0.649
|
|
|
|
cellular lipid catabolic process
|
GO:0044242 |
52 |
0.642
|
|
|
|
fatty acid metabolic process
|
GO:0006631 |
121 |
0.605
|
|
|
|
lipid catabolic process
|
GO:0016042 |
69 |
0.583
|
|
|
|
toxin catabolic process
|
GO:0009407 |
1 |
0.570
|
|
|
|
fatty acid catabolic process
|
GO:0009062 |
25 |
0.510
|
|
|
|
xenobiotic catabolic process
|
GO:0042178 |
1 |
0.487
|
|
|
|
neutral lipid metabolic process
|
GO:0006638 |
57 |
0.442
|
|
|
|
lipid biosynthetic process
|
GO:0008610 |
179 |
0.390
|
|
|
|
response to organic cyclic compound
|
GO:0014070 |
198 |
0.379
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.373
|
|
|
|
activation of membrane attack complex
|
GO:0001905 |
4 |
0.350
|
|
|
|
plasma lipoprotein particle clearance
|
GO:0034381 |
13 |
0.341
|
|
|
|
triglyceride metabolic process
|
GO:0006641 |
51 |
0.339
|
|
|
|
leukocyte mediated immunity
|
GO:0002443 |
174 |
0.291
|
|
|
|
acylglycerol metabolic process
|
GO:0006639 |
55 |
0.289
|
|
|
|
negative regulation of nitric oxide synthase biosynthetic process
|
GO:0051771 |
1 |
0.287
|
|
|
|
alpha amino acid metabolic process
|
GO:1901605 |
59 |
0.286
|
|
|
|
establishment of blood nerve barrier
|
GO:0008065 |
3 |
0.261
|
|
|
|
sterol metabolic process
|
GO:0016125 |
58 |
0.258
|
Mouse |
|
|
regulation of phagocytosis
|
GO:0050764 |
33 |
0.255
|
|
|
|
response to acid chemical
|
GO:0001101 |
111 |
0.229
|
|
|
|
organic heteropentacyclic compound catabolic process
|
GO:1901377 |
1 |
0.227
|
|
|
|
carbohydrate catabolic process
|
GO:0016052 |
32 |
0.223
|
|
|
|
sulfur compound metabolic process
|
GO:0006790 |
100 |
0.217
|
|
|
|
lipid modification
|
GO:0030258 |
65 |
0.201
|
|
|
|
superoxide metabolic process
|
GO:0006801 |
27 |
0.191
|
|
|
|
positive regulation of t cell mediated cytotoxicity
|
GO:0001916 |
15 |
0.185
|
|
|
|
response to metal ion
|
GO:0010038 |
47 |
0.184
|
|
|
|
regulation of apoptotic signaling pathway
|
GO:2001233 |
197 |
0.184
|
|
|
|
regulation of beta amyloid clearance
|
GO:1900221 |
1 |
0.174
|
|
|
|
secondary metabolite catabolic process
|
GO:0090487 |
1 |
0.172
|
|
|
|
generation of precursor metabolites and energy
|
GO:0006091 |
103 |
0.168
|
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
306 |
0.166
|
|
|
|
protein activation cascade
|
GO:0072376 |
19 |
0.165
|
|
|
|
alcohol metabolic process
|
GO:0006066 |
116 |
0.165
|
Mouse |
|
|
organonitrogen compound catabolic process
|
GO:1901565 |
264 |
0.155
|
|
|
|
carbohydrate metabolic process
|
GO:0005975 |
230 |
0.153
|
|
|
|
male gamete generation
|
GO:0048232 |
285 |
0.148
|
|
|
|
positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains
|
GO:0002824 |
61 |
0.147
|
|
|
|
glycerolipid metabolic process
|
GO:0046486 |
122 |
0.143
|
|
|
|
nadph regeneration
|
GO:0006740 |
2 |
0.143
|
|
|
|
regulation of plasma lipoprotein particle levels
|
GO:0097006 |
23 |
0.143
|
|
|
|
positive regulation of activation of membrane attack complex
|
GO:0001970 |
2 |
0.141
|
|
|
|
positive regulation of endocytosis
|
GO:0045807 |
42 |
0.139
|
|
|
|
regulation of lymphocyte mediated immunity
|
GO:0002706 |
84 |
0.137
|
|
|
|
response to oxidative stress
|
GO:0006979 |
123 |
0.136
|
|
|
|
lipid localization
|
GO:0010876 |
126 |
0.133
|
|
|
|
cofactor metabolic process
|
GO:0051186 |
80 |
0.132
|
|
|
|
response to reactive oxygen species
|
GO:0000302 |
56 |
0.126
|
|
|
|
response to molecule of bacterial origin
|
GO:0002237 |
143 |
0.121
|
|
|
|
organic hydroxy compound catabolic process
|
GO:1901616 |
25 |
0.118
|
|
|
|
positive regulation of phagocytosis
|
GO:0050766 |
26 |
0.116
|
|
|
|
response to extracellular stimulus
|
GO:0009991 |
127 |
0.115
|
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
247 |
0.110
|
|
|
|
spermatogenesis
|
GO:0007283 |
284 |
0.110
|
|
|
|
response to steroid hormone
|
GO:0048545 |
56 |
0.102
|
|
|
|
benzene containing compound metabolic process
|
GO:0042537 |
5 |
0.102
|
|
|
|
negative regulation of molecular function
|
GO:0044092 |
258 |
0.098
|
|
|
|
multicellular organismal homeostasis
|
GO:0048871 |
164 |
0.097
|
|
|
|
regulation of peptidase activity
|
GO:0052547 |
96 |
0.096
|
|
|
|
positive regulation of immune effector process
|
GO:0002699 |
107 |
0.095
|
|
|
|
cholesterol storage
|
GO:0010878 |
4 |
0.092
|
|
|
|
aflatoxin catabolic process
|
GO:0046223 |
1 |
0.089
|
|
|
|
regulation of phospholipid catabolic process
|
GO:0060696 |
2 |
0.087
|
|
|
|
reactive nitrogen species metabolic process
|
GO:2001057 |
0 |
0.084
|
|
|
|
terpenoid metabolic process
|
GO:0006721 |
25 |
0.083
|
|
|
|
cellular response to hormone stimulus
|
GO:0032870 |
150 |
0.082
|
|
|
|
lipid oxidation
|
GO:0034440 |
29 |
0.081
|
|
|
|
sterol homeostasis
|
GO:0055092 |
45 |
0.079
|
|
|
|
leukocyte mediated cytotoxicity
|
GO:0001909 |
62 |
0.078
|
|
|
|
immune effector process
|
GO:0002252 |
321 |
0.078
|
|
|
|
positive regulation of leukocyte mediated cytotoxicity
|
GO:0001912 |
31 |
0.077
|
|
|
|
organic hydroxy compound metabolic process
|
GO:1901615 |
203 |
0.075
|
Mouse |
|
|
regulation of leukocyte mediated immunity
|
GO:0002703 |
104 |
0.075
|
|
|
|
acylglycerol biosynthetic process
|
GO:0046463 |
18 |
0.073
|
|
|
|
organic cyclic compound catabolic process
|
GO:1901361 |
295 |
0.073
|
|
|
|
response to phenylpropanoid
|
GO:0080184 |
22 |
0.072
|
|
|
|
positive regulation of reactive oxygen species metabolic process
|
GO:2000379 |
11 |
0.071
|
|
|
|
coagulation
|
GO:0050817 |
78 |
0.070
|
|
|
|
heart morphogenesis
|
GO:0003007 |
178 |
0.066
|
|
|
|
reactive oxygen species metabolic process
|
GO:0072593 |
84 |
0.066
|
|
|
|
regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains
|
GO:0002822 |
87 |
0.065
|
|
|
|
glucan metabolic process
|
GO:0044042 |
32 |
0.065
|
|
|
|
regulation of endocytosis
|
GO:0030100 |
69 |
0.064
|
|
|
|
cellular response to hexose stimulus
|
GO:0071331 |
47 |
0.064
|
|
|
|
reverse cholesterol transport
|
GO:0043691 |
6 |
0.064
|
|
|
|
cell adhesion
|
GO:0007155 |
329 |
0.063
|
|
|
|
cholesterol catabolic process
|
GO:0006707 |
5 |
0.063
|
|
|
|
toxin metabolic process
|
GO:0009404 |
5 |
0.063
|
|
|
|
response to lipopolysaccharide
|
GO:0032496 |
128 |
0.062
|
|
|
|
cellular response to molecule of bacterial origin
|
GO:0071219 |
83 |
0.062
|
|
|
|
monocyte chemotactic protein 1 production
|
GO:0071605 |
1 |
0.062
|
|
|
|
response to peptide hormone
|
GO:0043434 |
127 |
0.062
|
|
|
|
phagocytosis
|
GO:0006909 |
66 |
0.061
|
|
|
|
cellular response to glucose stimulus
|
GO:0071333 |
45 |
0.060
|
|
|
|
regulation of endopeptidase activity
|
GO:0052548 |
89 |
0.058
|
|
|
|
regulation of reactive oxygen species metabolic process
|
GO:2000377 |
40 |
0.058
|
|
|
|
response to inorganic substance
|
GO:0010035 |
96 |
0.058
|
|
|
|
cellular chemical homeostasis
|
GO:0055082 |
215 |
0.057
|
|
|
|
cellular homeostasis
|
GO:0019725 |
240 |
0.056
|
|
|
|
response to hydroperoxide
|
GO:0033194 |
6 |
0.056
|
|
|
|
regulation of extrinsic apoptotic signaling pathway
|
GO:2001236 |
77 |
0.056
|
|
|
|
lymphocyte mediated immunity
|
GO:0002449 |
139 |
0.056
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.055
|
|
|
|
sterol catabolic process
|
GO:0016127 |
5 |
0.055
|
|
|
|
regulation of triglyceride biosynthetic process
|
GO:0010866 |
10 |
0.054
|
|
|
|
regulation of protein activation cascade
|
GO:2000257 |
7 |
0.054
|
|
|
|
response to alcohol
|
GO:0097305 |
48 |
0.053
|
|
|
|
icosanoid metabolic process
|
GO:0006690 |
33 |
0.053
|
|
|
|
positive regulation of lymphocyte mediated immunity
|
GO:0002708 |
62 |
0.052
|
|
|
|
reactive oxygen species biosynthetic process
|
GO:1903409 |
8 |
0.052
|
|
|
|
cellular response to oxidative stress
|
GO:0034599 |
76 |
0.051
|
|
|
|
response to monosaccharide
|
GO:0034284 |
67 |
0.050
|
|
|
|
regulation of reactive oxygen species biosynthetic process
|
GO:1903426 |
2 |
0.050
|
|
|
|
protein processing
|
GO:0016485 |
163 |
0.050
|
|
|
|
cellular response to monosaccharide stimulus
|
GO:0071326 |
47 |
0.050
|
|
|
|
positive regulation of mapk cascade
|
GO:0043410 |
170 |
0.049
|
|
|
|
adaptive immune response
|
GO:0002250 |
155 |
0.049
|
|
|
|
regulation of kinase activity
|
GO:0043549 |
249 |
0.048
|
|
|
|
regulation of protein kinase activity
|
GO:0045859 |
232 |
0.047
|
|
|
|
organ regeneration
|
GO:0031100 |
2 |
0.047
|
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
296 |
0.047
|
|
|
|
response to testosterone
|
GO:0033574 |
3 |
0.047
|
|
|
|
negative regulation of apoptotic signaling pathway
|
GO:2001234 |
104 |
0.047
|
|
|
|
response to peptide
|
GO:1901652 |
136 |
0.047
|
|
|
|
negative regulation of monocyte chemotactic protein 1 production
|
GO:0071638 |
1 |
0.047
|
|
|
|
skeletal system development
|
GO:0001501 |
356 |
0.046
|
|
|
|
intracellular cholesterol transport
|
GO:0032367 |
3 |
0.046
|
|
|
|
positive regulation of lipid storage
|
GO:0010884 |
10 |
0.046
|
|
|
|
endocytosis
|
GO:0006897 |
168 |
0.045
|
|
|
|
regulation of hormone levels
|
GO:0010817 |
211 |
0.045
|
|
|
|
vitamin metabolic process
|
GO:0006766 |
23 |
0.045
|
|
|
|
aspartate family amino acid metabolic process
|
GO:0009066 |
10 |
0.044
|
|
|
|
hexose catabolic process
|
GO:0019320 |
3 |
0.044
|
|
|
|
regulation of lipid transport
|
GO:0032368 |
36 |
0.044
|
|
|
|
response to nutrient levels
|
GO:0031667 |
109 |
0.043
|
|
|
|
liver development
|
GO:0001889 |
66 |
0.043
|
|
|
|
positive regulation of apoptotic signaling pathway
|
GO:2001235 |
95 |
0.043
|
|
|
|
cholesterol homeostasis
|
GO:0042632 |
44 |
0.043
|
|
|
|
hepaticobiliary system development
|
GO:0061008 |
67 |
0.042
|
|
|
|
regulation of vesicle mediated transport
|
GO:0060627 |
139 |
0.042
|
|
|
|
intrinsic apoptotic signaling pathway
|
GO:0097193 |
132 |
0.041
|
|
|
|
cellular response to lipopolysaccharide
|
GO:0071222 |
77 |
0.041
|
|
|
|
regulation of intrinsic apoptotic signaling pathway
|
GO:2001242 |
61 |
0.040
|
|
|
|
monosaccharide metabolic process
|
GO:0005996 |
106 |
0.040
|
|
|
|
peripheral nervous system development
|
GO:0007422 |
53 |
0.040
|
|
|
|
cellular response to organic cyclic compound
|
GO:0071407 |
87 |
0.040
|
|
|
|
epithelial cell proliferation
|
GO:0050673 |
174 |
0.040
|
|
|
|
regulation of cell activation
|
GO:0050865 |
289 |
0.039
|
|
|
|
regulation of phosphatidylcholine catabolic process
|
GO:0010899 |
2 |
0.039
|
|
|
|
female meiosis chromosome segregation
|
GO:0016321 |
1 |
0.039
|
|
|
|
cellular response to carbohydrate stimulus
|
GO:0071322 |
50 |
0.039
|
|
|
|
regulation of complement activation
|
GO:0030449 |
7 |
0.038
|
|
|
|
positive regulation of sterol transport
|
GO:0032373 |
9 |
0.038
|
|
|
|
positive regulation of mitochondrial calcium ion concentration
|
GO:0051561 |
3 |
0.038
|
|
|
|
regulation of adaptive immune response
|
GO:0002819 |
90 |
0.038
|
|
|
|
small molecule biosynthetic process
|
GO:0044283 |
132 |
0.038
|
|
|
|
sphingolipid metabolic process
|
GO:0006665 |
45 |
0.038
|
|
|
|
negative regulation of proteolysis
|
GO:0045861 |
74 |
0.037
|
|
|
|
urogenital system development
|
GO:0001655 |
261 |
0.037
|
|
|
|
positive regulation of apoptotic cell clearance
|
GO:2000427 |
3 |
0.037
|
|
|
|
positive regulation of protein activation cascade
|
GO:2000259 |
2 |
0.037
|
|
|
|
lung development
|
GO:0030324 |
164 |
0.037
|
|
|
|
low density lipoprotein particle clearance
|
GO:0034383 |
8 |
0.037
|
|
|
|
anatomical structure homeostasis
|
GO:0060249 |
145 |
0.037
|
|
|
|
positive regulation of cholesterol storage
|
GO:0010886 |
3 |
0.036
|
|
|
|
t cell activation
|
GO:0042110 |
289 |
0.036
|
|
|
|
fatty acid derivative metabolic process
|
GO:1901568 |
33 |
0.035
|
|
|
|
sterol transport
|
GO:0015918 |
38 |
0.035
|
|
|
|
triglyceride biosynthetic process
|
GO:0019432 |
17 |
0.035
|
|
|
|
short chain fatty acid metabolic process
|
GO:0046459 |
6 |
0.035
|
|
|
|
regulation of cholesterol metabolic process
|
GO:0090181 |
14 |
0.035
|
|
|
|
beta amyloid clearance
|
GO:0097242 |
2 |
0.035
|
|
|
|
isoprenoid metabolic process
|
GO:0006720 |
29 |
0.034
|
|
|
|
t cell differentiation
|
GO:0030217 |
174 |
0.033
|
|
|
|
alcohol catabolic process
|
GO:0046164 |
16 |
0.033
|
|
|
|
maintenance of location
|
GO:0051235 |
89 |
0.033
|
|
|
|
cholesterol metabolic process
|
GO:0008203 |
56 |
0.032
|
Mouse |
|
|
extrinsic apoptotic signaling pathway
|
GO:0097191 |
126 |
0.032
|
|
|
|
response to oxygen radical
|
GO:0000305 |
16 |
0.032
|
|
|
|
hydrogen peroxide catabolic process
|
GO:0042744 |
5 |
0.032
|
|
|
|
spermatid differentiation
|
GO:0048515 |
115 |
0.032
|
|
|
|
protein maturation
|
GO:0051604 |
176 |
0.032
|
|
|
|
very long chain fatty acid metabolic process
|
GO:0000038 |
8 |
0.032
|
|
|
|
regulation of cellular catabolic process
|
GO:0031329 |
242 |
0.032
|
|
|
|
multicellular organism growth
|
GO:0035264 |
161 |
0.032
|
|
|
|
cellular response to oxygen radical
|
GO:0071450 |
14 |
0.032
|
|
|
|
gland development
|
GO:0048732 |
330 |
0.032
|
|
|
|
regulation of leukocyte mediated cytotoxicity
|
GO:0001910 |
38 |
0.031
|
|
|
|
positive regulation of protein modification process
|
GO:0031401 |
299 |
0.031
|
|
|
|
glycosylation
|
GO:0070085 |
62 |
0.031
|
|
|
|
monosaccharide biosynthetic process
|
GO:0046364 |
44 |
0.031
|
|
|
|
regulation of coagulation
|
GO:0050818 |
31 |
0.031
|
|
|
|
positive regulation of protein phosphorylation
|
GO:0001934 |
242 |
0.031
|
|
|
|
innate immune response
|
GO:0045087 |
157 |
0.031
|
|
|
|
cellular glucose homeostasis
|
GO:0001678 |
52 |
0.030
|
|
|
|
lymphocyte differentiation
|
GO:0030098 |
242 |
0.030
|
|
|
|
lipid storage
|
GO:0019915 |
36 |
0.030
|
|
|
|
posttranscriptional regulation of gene expression
|
GO:0010608 |
155 |
0.030
|
|
|
|
blood coagulation
|
GO:0007596 |
76 |
0.030
|
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
282 |
0.029
|
|
|
|
hydrogen peroxide metabolic process
|
GO:0042743 |
16 |
0.029
|
|
|
|
peptidyl tyrosine modification
|
GO:0018212 |
145 |
0.029
|
|
|
|
nucleocytoplasmic transport
|
GO:0006913 |
139 |
0.029
|
|
|
|
positive regulation of coagulation
|
GO:0050820 |
13 |
0.028
|
|
|
|
steroid metabolic process
|
GO:0008202 |
119 |
0.028
|
Mouse |
|
|
pentose phosphate shunt
|
GO:0006098 |
2 |
0.028
|
|
|
|
response to stilbenoid
|
GO:0035634 |
22 |
0.028
|
|
|
|
aflatoxin metabolic process
|
GO:0046222 |
1 |
0.027
|
|
|
|
coenzyme metabolic process
|
GO:0006732 |
52 |
0.027
|
|
|
|
positive regulation of steroid biosynthetic process
|
GO:0010893 |
4 |
0.027
|
|
|
|
cellular carbohydrate catabolic process
|
GO:0044275 |
15 |
0.027
|
|
|
|
epithelial cell development
|
GO:0002064 |
159 |
0.027
|
|
|
|
regulation of body fluid levels
|
GO:0050878 |
162 |
0.027
|
|
|
|
positive regulation of lipid biosynthetic process
|
GO:0046889 |
18 |
0.026
|
|
|
|
cell killing
|
GO:0001906 |
67 |
0.026
|
|
|
|
energy derivation by oxidation of organic compounds
|
GO:0015980 |
77 |
0.026
|
|
|
|
positive regulation of apoptotic process
|
GO:0043065 |
217 |
0.026
|
|
|
|
iron ion transport
|
GO:0006826 |
17 |
0.026
|
|
|
|
protein oligomerization
|
GO:0051259 |
67 |
0.026
|
|
|
|
t cell mediated cytotoxicity
|
GO:0001913 |
26 |
0.026
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.026
|
|
|
|
positive regulation of myeloid leukocyte mediated immunity
|
GO:0002888 |
14 |
0.025
|
|
|
|
cellular response to cadmium ion
|
GO:0071276 |
3 |
0.025
|
|
|
|
phospholipid transfer to membrane
|
GO:0006649 |
2 |
0.025
|
|
|
|
regulation of homeostatic process
|
GO:0032844 |
182 |
0.025
|
|
|
|
amide transport
|
GO:0042886 |
138 |
0.025
|
|
|
|
carbohydrate homeostasis
|
GO:0033500 |
128 |
0.025
|
|
|
|
tumor necrosis factor production
|
GO:0032640 |
50 |
0.025
|
|
|
|
response to organonitrogen compound
|
GO:0010243 |
246 |
0.025
|
|
|
|
negative regulation of peroxidase activity
|
GO:2000469 |
1 |
0.024
|
|
|
|
positive regulation of response to wounding
|
GO:1903036 |
66 |
0.024
|
|
|
|
neuromuscular process controlling balance
|
GO:0050885 |
59 |
0.024
|
|
|
|
regulation of protein stability
|
GO:0031647 |
52 |
0.024
|
|
|
|
retina homeostasis
|
GO:0001895 |
23 |
0.024
|
|
|
|
secondary metabolic process
|
GO:0019748 |
18 |
0.024
|
|
|
|
regulation of protein maturation
|
GO:1903317 |
96 |
0.024
|
|
|
|
regulation of proteolysis
|
GO:0030162 |
164 |
0.024
|
|
|
|
glucose catabolic process
|
GO:0006007 |
3 |
0.023
|
|
|
|
defense response to bacterium
|
GO:0042742 |
119 |
0.023
|
|
|
|
antigen processing and presentation of endogenous peptide antigen via mhc class i via er pathway
|
GO:0002484 |
3 |
0.023
|
|
|
|
wound healing
|
GO:0042060 |
157 |
0.023
|
|
|
|
macromolecule glycosylation
|
GO:0043413 |
55 |
0.023
|
|
|
|
positive regulation of phagocytosis engulfment
|
GO:0060100 |
3 |
0.023
|
|
|
|
prostaglandin metabolic process
|
GO:0006693 |
11 |
0.023
|
|
|
|
response to superoxide
|
GO:0000303 |
16 |
0.023
|
|
|
|
regulation of transferase activity
|
GO:0051338 |
263 |
0.022
|
|
|
|
glucose homeostasis
|
GO:0042593 |
128 |
0.022
|
|
|
|
phospholipid catabolic process
|
GO:0009395 |
5 |
0.022
|
|
|
|
gonad development
|
GO:0008406 |
141 |
0.022
|
|
|
|
cellular response to testosterone stimulus
|
GO:0071394 |
1 |
0.022
|
|
|
|
regulation of removal of superoxide radicals
|
GO:2000121 |
4 |
0.022
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.022
|
|
|
|
regulation of peptide transport
|
GO:0090087 |
91 |
0.022
|
|
|
|
cell activation involved in immune response
|
GO:0002263 |
126 |
0.022
|
|
|
|
peptidyl amino acid modification
|
GO:0018193 |
336 |
0.021
|
|
|
|
cellular response to food
|
GO:0071240 |
1 |
0.021
|
|
|
|
kidney development
|
GO:0001822 |
213 |
0.021
|
|
|
|
regulation of tumor necrosis factor superfamily cytokine production
|
GO:1903555 |
50 |
0.021
|
|
|
|
cellular response to extracellular stimulus
|
GO:0031668 |
81 |
0.021
|
|
|
|
positive regulation of nf kappab transcription factor activity
|
GO:0051092 |
30 |
0.021
|
|
|
|
lymphocyte activation involved in immune response
|
GO:0002285 |
93 |
0.020
|
|
|
|
nuclear transport
|
GO:0051169 |
139 |
0.020
|
|
|
|
regulation of blood coagulation
|
GO:0030193 |
28 |
0.020
|
|
|
|
dicarboxylic acid metabolic process
|
GO:0043648 |
18 |
0.020
|
|
|
|
protein glycosylation
|
GO:0006486 |
55 |
0.020
|
|
|
|
cellular protein catabolic process
|
GO:0044257 |
155 |
0.020
|
|
|
|
amine metabolic process
|
GO:0009308 |
45 |
0.020
|
|
|
|
regulation of triglyceride metabolic process
|
GO:0090207 |
17 |
0.020
|
|
|
|
respiratory system development
|
GO:0060541 |
190 |
0.020
|
|
|
|
cellular response to biotic stimulus
|
GO:0071216 |
92 |
0.020
|
|
|
|
development of primary sexual characteristics
|
GO:0045137 |
143 |
0.020
|
|
|
|
intracellular sterol transport
|
GO:0032366 |
3 |
0.020
|
|
|
|
skeletal system morphogenesis
|
GO:0048705 |
203 |
0.019
|
|
|
|
cellular response to bacterial lipopeptide
|
GO:0071221 |
3 |
0.019
|
|
|
|
cellular alcohol metabolic process
|
GO:0044107 |
3 |
0.019
|
|
|
|
glycerolipid catabolic process
|
GO:0046503 |
16 |
0.019
|
|
|
|
glycolytic process
|
GO:0006096 |
20 |
0.019
|
|
|
|
negative regulation of insulin secretion involved in cellular response to glucose stimulus
|
GO:0061179 |
4 |
0.019
|
|
|
|
mitochondrial calcium ion homeostasis
|
GO:0051560 |
7 |
0.019
|
|
|
|
negative regulation of endopeptidase activity
|
GO:0010951 |
44 |
0.019
|
|
|
|
tumor necrosis factor superfamily cytokine production
|
GO:0071706 |
51 |
0.019
|
|
|
|
mapk cascade
|
GO:0000165 |
281 |
0.019
|
|
|
|
cellular amino acid catabolic process
|
GO:0009063 |
25 |
0.018
|
|
|
|
ceramide metabolic process
|
GO:0006672 |
31 |
0.018
|
|
|
|
regulation of defense response
|
GO:0031347 |
233 |
0.018
|
|
|
|
regulation of insulin secretion involved in cellular response to glucose stimulus
|
GO:0061178 |
31 |
0.018
|
|
|
|
regulation of lymphocyte activation
|
GO:0051249 |
240 |
0.018
|
|
|
|
positive regulation of proteolysis
|
GO:0045862 |
85 |
0.018
|
|
|
|
cation transport
|
GO:0006812 |
399 |
0.018
|
|
|
|
cellular response to starvation
|
GO:0009267 |
57 |
0.018
|
|
|
|
male sex differentiation
|
GO:0046661 |
109 |
0.018
|
|
|
|
positive regulation of proteolysis involved in cellular protein catabolic process
|
GO:1903052 |
31 |
0.018
|
|
|
|
membrane lipid biosynthetic process
|
GO:0046467 |
32 |
0.018
|
|
|
|
acute inflammatory response to antigenic stimulus
|
GO:0002438 |
12 |
0.018
|
|
|
|
endoplasmic reticulum calcium ion homeostasis
|
GO:0032469 |
11 |
0.018
|
|
|
|
response to hydrogen peroxide
|
GO:0042542 |
32 |
0.018
|
|
|
|
positive regulation of complement activation
|
GO:0045917 |
2 |
0.018
|
|
|
|
positive regulation of t cell activation
|
GO:0050870 |
101 |
0.017
|
|
|
|
production of molecular mediator of immune response
|
GO:0002440 |
103 |
0.017
|
|
|
|
cellular response to hydroperoxide
|
GO:0071447 |
4 |
0.017
|
|
|
|
positive regulation of lipid transport
|
GO:0032370 |
22 |
0.017
|
|
|
|
carbohydrate derivative biosynthetic process
|
GO:1901137 |
183 |
0.017
|
|
|
|
lipoprotein transport
|
GO:0042953 |
7 |
0.017
|
|
|
|
protein folding
|
GO:0006457 |
28 |
0.017
|
|
|
|
intracellular lipid transport
|
GO:0032365 |
3 |
0.017
|
|
|
|
regulation of type ii hypersensitivity
|
GO:0002892 |
4 |
0.017
|
|
|
|
lysosome organization
|
GO:0007040 |
21 |
0.017
|
|
|
|
drug catabolic process
|
GO:0042737 |
2 |
0.017
|
|
|
|
regulation of t cell activation
|
GO:0050863 |
170 |
0.017
|
|
|
|
regulation of protein targeting
|
GO:1903533 |
61 |
0.017
|
|
|
|
leukocyte proliferation
|
GO:0070661 |
172 |
0.017
|
|
|
|
cation homeostasis
|
GO:0055080 |
212 |
0.017
|
|
|
|
pyruvate metabolic process
|
GO:0006090 |
28 |
0.017
|
|
|
|
glutamine family amino acid biosynthetic process
|
GO:0009084 |
2 |
0.017
|
|
|
|
single fertilization
|
GO:0007338 |
82 |
0.017
|
|
|
|
cellular amino acid biosynthetic process
|
GO:0008652 |
22 |
0.017
|
|
|
|
response to epidermal growth factor
|
GO:0070849 |
4 |
0.017
|
|
|
|
regeneration
|
GO:0031099 |
38 |
0.016
|
|
|
|
macromolecule catabolic process
|
GO:0009057 |
281 |
0.016
|
|
|
|
negative regulation of immune system process
|
GO:0002683 |
209 |
0.016
|
|
|
|
regulation of b cell mediated immunity
|
GO:0002712 |
37 |
0.016
|
|
|
|
aromatic compound catabolic process
|
GO:0019439 |
286 |
0.016
|
|
|
|
rna interference
|
GO:0016246 |
2 |
0.016
|
|
|
|
response to xenobiotic stimulus
|
GO:0009410 |
13 |
0.016
|
|
|
|
protein tetramerization
|
GO:0051262 |
23 |
0.016
|
|
|
|
negative regulation of transferase activity
|
GO:0051348 |
85 |
0.016
|
|
|
|
organic heteropentacyclic compound metabolic process
|
GO:1901376 |
1 |
0.016
|
|
|
|
negative regulation of kinase activity
|
GO:0033673 |
81 |
0.016
|
|
|
|
vitamin d3 metabolic process
|
GO:0070640 |
3 |
0.016
|
|
|
|
adiponectin activated signaling pathway
|
GO:0033211 |
4 |
0.016
|
|
|
|
positive regulation of transferase activity
|
GO:0051347 |
167 |
0.016
|
|
|
|
insulin secretion involved in cellular response to glucose stimulus
|
GO:0035773 |
36 |
0.016
|
|
|
|
cholesterol import
|
GO:0070508 |
2 |
0.016
|
|
|
|
gliogenesis
|
GO:0042063 |
141 |
0.016
|
|
|
|
regulation of immunoglobulin mediated immune response
|
GO:0002889 |
37 |
0.016
|
|
|
|
renal system development
|
GO:0072001 |
225 |
0.016
|
|
|
|
inclusion body assembly
|
GO:0070841 |
3 |
0.016
|
|
|
|
protein localization to organelle
|
GO:0033365 |
185 |
0.016
|
|
|
|
angiotensin mediated vasoconstriction involved in regulation of systemic arterial blood pressure
|
GO:0001998 |
3 |
0.016
|
|
|
|
negative regulation of protein processing
|
GO:0010955 |
79 |
0.016
|
|
|
|
regulation of peroxidase activity
|
GO:2000468 |
1 |
0.016
|
|
|
|
dopamine catabolic process
|
GO:0042420 |
4 |
0.016
|
|
|
|
tricarboxylic acid metabolic process
|
GO:0072350 |
5 |
0.016
|
|
|
|
hexose metabolic process
|
GO:0019318 |
98 |
0.015
|
|
|
|
response to nitrosative stress
|
GO:0051409 |
1 |
0.015
|
|
|
|
pyridine containing compound metabolic process
|
GO:0072524 |
14 |
0.015
|
|
|
|
glycogen metabolic process
|
GO:0005977 |
32 |
0.015
|
|
|
|
cellular response to lipid
|
GO:0071396 |
145 |
0.015
|
|
|
|
positive regulation of triglyceride metabolic process
|
GO:0090208 |
9 |
0.015
|
|
|
|
cellular glucan metabolic process
|
GO:0006073 |
32 |
0.015
|
|
|
|
positive regulation of adaptive immune response
|
GO:0002821 |
61 |
0.015
|
|
|
|
sterol transmembrane transport
|
GO:0035382 |
2 |
0.015
|
|
|
|
cell recognition
|
GO:0008037 |
83 |
0.015
|
|
|
|
striated muscle myosin thick filament assembly
|
GO:0071688 |
1 |
0.015
|
|
|
|
regulation of protein serine threonine kinase activity
|
GO:0071900 |
157 |
0.015
|
|
|
|
negative regulation of oxidoreductase activity
|
GO:0051354 |
4 |
0.015
|
|
|
|
nuclear import
|
GO:0051170 |
95 |
0.015
|
|
|
|
complement activation
|
GO:0006956 |
16 |
0.015
|
|
|
|
membrane depolarization
|
GO:0051899 |
64 |
0.015
|
|
|
|
dna metabolic process
|
GO:0006259 |
303 |
0.015
|
|
|
|
positive regulation of lymphocyte activation
|
GO:0051251 |
140 |
0.015
|
|
|
|
secondary alcohol metabolic process
|
GO:1902652 |
3 |
0.015
|
|
|
|
energy reserve metabolic process
|
GO:0006112 |
39 |
0.015
|
|
|
|
response to endoplasmic reticulum stress
|
GO:0034976 |
53 |
0.015
|
|
|
|
cellular response to cytokine stimulus
|
GO:0071345 |
189 |
0.015
|
|
|
|
organonitrogen compound biosynthetic process
|
GO:1901566 |
192 |
0.014
|
|
|
|
fat soluble vitamin biosynthetic process
|
GO:0042362 |
4 |
0.014
|
|
|
|
myosin filament assembly
|
GO:0031034 |
2 |
0.014
|
|
|
|
multi multicellular organism process
|
GO:0044706 |
109 |
0.014
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.014
|
|
|
|
positive regulation of peptidyl tyrosine phosphorylation
|
GO:0050731 |
61 |
0.014
|
|
|
|
hatching
|
GO:0035188 |
4 |
0.014
|
|
|
|
antigen processing and presentation of endogenous peptide antigen via mhc class i
|
GO:0019885 |
3 |
0.014
|
|
|
|
positive regulation of cholesterol transport
|
GO:0032376 |
9 |
0.014
|
|
|
|
removal of superoxide radicals
|
GO:0019430 |
12 |
0.014
|
|
|
|
cellular response to superoxide
|
GO:0071451 |
14 |
0.014
|
|
|
|
diterpenoid metabolic process
|
GO:0016101 |
24 |
0.014
|
|
|
|
respiratory tube development
|
GO:0030323 |
167 |
0.014
|
|
|
|
regulation of sequence specific dna binding transcription factor activity
|
GO:0051090 |
106 |
0.014
|
|
|
|
negative regulation of planar cell polarity pathway involved in cardiac muscle tissue morphogenesis
|
GO:2000151 |
1 |
0.014
|
|
|
|
t cell mediated immunity
|
GO:0002456 |
50 |
0.014
|
|
|
|
positive regulation of cell death
|
GO:0010942 |
224 |
0.014
|
|
|
|
negative regulation of extrinsic apoptotic signaling pathway
|
GO:2001237 |
45 |
0.014
|
|
|
|
striated muscle tissue development
|
GO:0014706 |
293 |
0.014
|
|
|
|
stem cell differentiation
|
GO:0048863 |
268 |
0.014
|
|
|
|
positive regulation of b cell mediated immunity
|
GO:0002714 |
26 |
0.014
|
|
|
|
cellular response to epidermal growth factor stimulus
|
GO:0071364 |
4 |
0.014
|
|
|
|
cholesterol transport
|
GO:0030301 |
38 |
0.014
|
|
|
|
negative regulation of protein maturation
|
GO:1903318 |
79 |
0.014
|
|
|
|
hormone metabolic process
|
GO:0042445 |
86 |
0.014
|
|
|
|
axonogenesis
|
GO:0007409 |
274 |
0.014
|
|
|
|
palate development
|
GO:0060021 |
76 |
0.014
|
|
|
|
drug metabolic process
|
GO:0017144 |
4 |
0.014
|
|
|
|
cellular response to organonitrogen compound
|
GO:0071417 |
145 |
0.014
|
|
|
|
regulation of cysteine type endopeptidase activity
|
GO:2000116 |
65 |
0.013
|
|
|
|
positive regulation of protein localization to cell surface
|
GO:2000010 |
2 |
0.013
|
|
|
|
regulation of hypersensitivity
|
GO:0002883 |
10 |
0.013
|
|
|
|
transition metal ion transport
|
GO:0000041 |
38 |
0.013
|
|
|
|
response to temperature stimulus
|
GO:0009266 |
55 |
0.013
|
|
|
|
positive regulation of kinase activity
|
GO:0033674 |
155 |
0.013
|
|
|
|
fibrinolysis
|
GO:0042730 |
3 |
0.013
|
|
|
|
cellular metal ion homeostasis
|
GO:0006875 |
151 |
0.013
|
|
|
|
regulation of t cell mediated cytotoxicity
|
GO:0001914 |
18 |
0.013
|
|
|
|
divalent inorganic cation transport
|
GO:0072511 |
178 |
0.013
|
|
|
|
cellular respiration
|
GO:0045333 |
38 |
0.013
|
|
|
|
response to heat
|
GO:0009408 |
27 |
0.013
|
|
|
|
regulation of lipid metabolic process
|
GO:0019216 |
118 |
0.013
|
|
|
|
bone resorption
|
GO:0045453 |
38 |
0.013
|
|
|
|
regulation of lipid biosynthetic process
|
GO:0046890 |
54 |
0.013
|
|
|
|
tissue homeostasis
|
GO:0001894 |
115 |
0.013
|
|
|
|
peroxisome organization
|
GO:0007031 |
7 |
0.013
|
|
|
|
positive regulation of intrinsic apoptotic signaling pathway
|
GO:2001244 |
25 |
0.013
|
|
|
|
heme metabolic process
|
GO:0042168 |
16 |
0.013
|
|
|
|
regulation of peptidyl tyrosine phosphorylation
|
GO:0050730 |
93 |
0.013
|
|
|
|
glycoprotein biosynthetic process
|
GO:0009101 |
89 |
0.013
|
|
|
|
canonical wnt signaling pathway involved in cardiac neural crest cell differentiation involved in heart development
|
GO:0061310 |
1 |
0.013
|
|
|
|
regulation of protein processing
|
GO:0070613 |
96 |
0.013
|
|
|
|
sphingolipid biosynthetic process
|
GO:0030148 |
26 |
0.013
|
|
|
|
pyridine nucleotide metabolic process
|
GO:0019362 |
12 |
0.013
|
|
|
|
positive regulation of inflammatory response to antigenic stimulus
|
GO:0002863 |
11 |
0.013
|
|
|
|
intracellular protein transport
|
GO:0006886 |
204 |
0.013
|
|
|
|
positive regulation of lipid metabolic process
|
GO:0045834 |
40 |
0.013
|
|
|
|
cytokine production involved in immune response
|
GO:0002367 |
34 |
0.013
|
|
|
|
inflammatory response to antigenic stimulus
|
GO:0002437 |
30 |
0.012
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.012
|
|
|
|
regulation of nucleocytoplasmic transport
|
GO:0046822 |
73 |
0.012
|
|
|
|
nitric oxide metabolic process
|
GO:0046209 |
25 |
0.012
|
|
|
|
cell proliferation in external granule layer
|
GO:0021924 |
10 |
0.012
|
|
|
|
acute inflammatory response
|
GO:0002526 |
41 |
0.012
|
|
|
|
neutral lipid biosynthetic process
|
GO:0046460 |
18 |
0.012
|
|
|
|
lytic vacuole organization
|
GO:0080171 |
21 |
0.012
|
|
|
|
phospholipid transport
|
GO:0015914 |
21 |
0.012
|
|
|
|
sperm motility
|
GO:0030317 |
47 |
0.012
|
|
|
|
negative regulation of cellular amide metabolic process
|
GO:0034249 |
4 |
0.012
|
|
|
|
porphyrin containing compound metabolic process
|
GO:0006778 |
22 |
0.012
|
|
|
|
calcitriol biosynthetic process from calciol
|
GO:0036378 |
3 |
0.012
|
|
|
|
negative regulation of planar cell polarity pathway involved in cardiac right atrium morphogenesis
|
GO:2000162 |
1 |
0.012
|
|
|
|
regulation of intracellular transport
|
GO:0032386 |
159 |
0.012
|
|
|
|
planar cell polarity pathway involved in pericardium morphogenesis
|
GO:0061354 |
2 |
0.012
|
|
|
|
plasma lipoprotein particle organization
|
GO:0071827 |
11 |
0.012
|
|
|
|
response to oxygen levels
|
GO:0070482 |
62 |
0.012
|
|
|
|
regulation of monocyte chemotactic protein 1 production
|
GO:0071637 |
1 |
0.012
|
|
|
|
cellular response to external stimulus
|
GO:0071496 |
88 |
0.012
|
|
|
|
adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains
|
GO:0002460 |
145 |
0.012
|
|
|
|
citrulline metabolic process
|
GO:0000052 |
3 |
0.012
|
|
|
|
nadp metabolic process
|
GO:0006739 |
6 |
0.012
|
|
|
|
positive regulation of programmed cell death
|
GO:0043068 |
218 |
0.012
|
|
|
|
muscle tissue development
|
GO:0060537 |
308 |
0.012
|
|
|
|
negative regulation of platelet derived growth factor receptor beta signaling pathway
|
GO:2000587 |
2 |
0.012
|
|